Hydroxychloroquine safety: comparison between no COVID-19 and
COVID-19 patients. Data from the Spanish Pharmacovigilance Database
M. Sainz-Gil, N. Merino Kolly, V. Velasco González, Z. Verde Rello, A.
M. Fernández Araque, R. Sanz Fadrique, L. H. Martín Arias.